Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 6, 2006 - Issue 8
Submit an article Journal homepage
231
Views
47
CrossRef citations to date
0
Altmetric
Drug Profile

Lenalidomide in multiple myeloma

Paul G Richardson Jerome Lipper Multiple Myeloma Center, Divison of Hematologic Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected]
,
Constantine Mitsiades Jerome Lipper Multiple Myeloma Center, Divison of Hematologic Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected]
,
Teru Hideshima Jerome Lipper Multiple Myeloma Center, Divison of Hematologic Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected]
&
Kenneth C Anderson Jerome Lipper Multiple Myeloma Center, Divison of Hematologic Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected]
Pages 1165-1173 | Published online: 10 Jan 2014

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Roberto Castelli, Nicola Orofino, Agnese Losurdo, Roberta Gualtierotti & Massimo Cugno. (2014) Choosing treatment options for patients with relapsed/refractory multiple myeloma. Expert Review of Anticancer Therapy 14:2, pages 199-215.
Read now
Douglas W. McMillin & Constantine S. Mitsiades. (2012) High-throughput approaches to discover novel immunomodulatory agents for cancer. OncoImmunology 1:8, pages 1406-1408.
Read now
Roberto Castelli, Antonino Cannavò, Fabio Conforti, Giovanni Grava & Agostino Cortelezzi. (2012) Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice. Immunopharmacology and Immunotoxicology 34:5, pages 740-753.
Read now
Ajay Nooka & Sagar Lonial. (2012) Sequential or combination therapy for multiple myeloma. Expert Review of Hematology 5:5, pages 533-545.
Read now
Selmin A Ataergin, Tamila Kindwall-Keller, Nathan A Berger & Hillard M Lazarus. (2009) New generation pharmacotherapy in elderly multiple myeloma patients. Expert Opinion on Pharmacotherapy 10:1, pages 81-98.
Read now
Aldo M Roccaro, Irene M Ghobrial, Simona Blotta, Steven P Treon, Michele Malagola, Kenneth C Anderson, Paul G Richardson & Domenico Russo. (2008) Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias. Biologics: Targets and Therapy 2:3, pages 419-431.
Read now
Patrizia Falco, Federica Cavallo, Alessandra Larocca, Anna Marina Liberati, Pellegrino Musto, Mario Boccadoro & Antonio Palumbo. (2008) Lenalidomide and its role in the management of multiple myeloma. Expert Review of Anticancer Therapy 8:6, pages 865-874.
Read now
Irene M Ghobrial, Xavier Leleu, Evdoxia Hatjiharissi, Teru Hideshima, Constantine Mitsiades, Robert Schlossman, Kenneth C Anderson & Paul Richardson. (2007) Emerging drugs in multiple myeloma. Expert Opinion on Emerging Drugs 12:1, pages 155-163.
Read now

Articles from other publishers (39)

Marion Mueller, Joseph Peakin & David J. Lewis. (2023) Practical Considerations for the Implementation and Monitoring of Risk Minimisation Measures for High-Risk Teratogenic Medicines. Pharmaceutical Medicine 37:6, pages 439-449.
Crossref
Guilherme F. S. Fernandes, Juliana R. Lopes, Jean L. Dos Santos & Cauê B. Scarim. (2023) Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activities. Drug Development Research 84:7, pages 1346-1375.
Crossref
Gyan Vardhan, Vikas Kumar, Puran Lal Sahu, Anuj Prakash, Uttam Kumar Nath, Shailendra Handu & Puneet Dhamija. (2022) Development and validation of a novel chiral chromatographic method for separation of lenalidomide enantiomers in human plasma. Chirality 35:2, pages 83-91.
Crossref
Junichi Yamamoto, Tomoko Asatsuma‐Okumura, Takumi Ito, Yuki Yamaguchi & Hiroshi Handa. 2022. Protein Homeostasis in Drug Discovery. Protein Homeostasis in Drug Discovery 283 315 .
Meng-Yan Deng, Khalil Ali Ahmad, Qiao-Qiao Han, Zi-Ying Wang, Rana Muhammad Shoaib, Xin-Yan Li & Yong-Xiang Wang. (2021) Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway. Biochemical Pharmacology 192, pages 114727.
Crossref
Rongrong Li, Bo Zhao, Xianlang Chen, Jieyu Zhang, Zhiying Liu, Xianling Zhu & Deman Han. (2021) Solubility and apparent thermodynamic analysis of pomalidomide in (acetone + ethanol/isopropanol) and (ethyl acetate + ethanol/isopropanol) and its correlation with thermodynamic model. The Journal of Chemical Thermodynamics 154, pages 106345.
Crossref
Bin-Bin Gu, Fu-Rong Jiao, Wei Wu, Wei-hua Jiao, Lei Li, Fan Sun, Shu-Ping Wang, Fan Yang & Hou-Wen Lin. (2018) Preussins with Inhibition of IL-6 Expression from Aspergillus flocculosus 16D-1, a Fungus Isolated from the Marine Sponge Phakellia fusca . Journal of Natural Products 81:10, pages 2275-2281.
Crossref
Jian Wu, Suresh Kumar, Feng Wang, Hui Wang, Lijia Chen, Patrick Arsenault, Michael Mattern & Joseph Weinstock. (2017) Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies. Journal of Medicinal Chemistry 61:2, pages 422-443.
Crossref
Arif E. Cetin, Mark M. Stevens, Nicholas L. Calistri, Mariateresa Fulciniti, Selim Olcum, Robert J. Kimmerling, Nikhil C. Munshi & Scott R. Manalis. (2017) Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation. Nature Communications 8:1.
Crossref
Rebecca Karp Leaf, Dina Stroopinsky, Athalia R. Pyzer, Ada M. Kruisbeek, Sandra van Wetering, Abigail Washington, Adam Ephraim, Leandra Cole, Adam Morin, Salvia Jain, Myrna R. Nahas, Arik Apel, Jon Arnason, Ayad Hamdan, Jacalyn Rosenblatt & David Avigan. (2017) DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma. Journal of Immunotherapy 40:9, pages 315-322.
Crossref
Veera Venkata Satyanarayana Reddy Karri, Nagasamy Venkatesh Dhandapani, Sai Sandeep Mannemala, Kollipara Radhakrishna, Shashank Mulukutla & Dedeepya Sudunagunta. (2017) Ameliorating the antitumor activity of lenalidomide using PLGA nanoparticles for the treatment of multiple myeloma. Brazilian Journal of Pharmaceutical Sciences 53:2.
Crossref
Rebecca Karp Leaf, Hearn Jay Cho & David Avigan. (2015) Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies. Current Hematologic Malignancy Reports 10:4, pages 395-404.
Crossref
Sakiko Tazawa, Eisuke Shiozawa, Mayumi Homma, Nana Arai, Nobuyuki Kabasawa, Yukiko Kawaguchi, Shun Fujiwara, Kazumaro Okino, Kae Kobayashi, Toshiko Yamochi, Genshu Tate, Tsuyoshi Nakamaki & Masafumi Takimoto. (2015) CD200 Expression on Plasma Cell Myeloma Cells is Associated with the Efficacies of Bortezomib, Lenalidomide and Thalidomide. Journal of Clinical and Experimental Hematopathology 55:3, pages 121-126.
Crossref
Thandapani Gomathi, C. Govindarajan, Maximas H. Rose H.R.P.N. Sudha, P.K. Mohamed Imran, Jayachandran Venkatesan & Se-Kwon Kim. (2014) Studies on drug-polymer interaction, in vitro release and cytotoxicity from chitosan particles excipient. International Journal of Pharmaceutics 468:1-2, pages 214-222.
Crossref
Douglas W. McMillin, Jake Delmore, Joseph M. Negri, Matthew Vanneman, Shohei Koyama, Robert L. Schlossman, Nikhil C. Munshi, Jacob Laubach, Paul G. Richardson, Glenn Dranoff, Kenneth C. Anderson & Constantine S. Mitsiades. (2012) Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function. Blood 119:15, pages e131-e138.
Crossref
Loredana Santo, Teru Hideshima, Diana Cirstea, Madhavi Bandi, Erik A. Nelson, Gullu Gorgun, Scott Rodig, Sonia Vallet, Samantha Pozzi, Kishan Patel, Christine Unitt, Matt Squires, Yiguo Hu, Dharminder Chauhan, Anuj Mahindra, Nikhil C. Munshi, Kenneth C. Anderson & Noopur Raje. (2011) Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide. Clinical Cancer Research 17:10, pages 3259-3271.
Crossref
Adrián Alegre, Beatriz Aguado, Pilar Giraldo, Eduardo Ríos, Araceli Cánovas, Ángela Ibáñez, Inmaculada Castillo, Miguel T. Hernández, Albert Oriol, Luis Palomera, Juan-N. Rodríguez, Flor-L. García, José M. Calvo, Carmen Martínez-Chamorro, Javier de la Serna & Juan-J. Lahuerta. (2011) Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients. International Journal of Hematology 93:3, pages 351-360.
Crossref
Deng Wei, Ya Mingxi, Xu Jianwang, Zhang Hao, Li Ming & Li Pei. (2011) Dexamethasone plus lenalidomide in treatment of multiple myeloma. Journal of Medical Colleges of PLA 26:1, pages 29-33.
Crossref
Tasnim Ara & Yves A. DeClerck. (2010) Interleukin-6 in bone metastasis and cancer progression. European Journal of Cancer 46:7, pages 1223-1231.
Crossref
Klaus Podar & Kenneth C. Anderson. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 2811 2819 .
M A Dimopoulos, C Chen, A Spencer, R Niesvizky, M Attal, E A Stadtmauer, M T Petrucci, Z Yu, M Olesnyckyj, J B Zeldis, R D Knight & D M Weber. (2009) Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. Leukemia 23:11, pages 2147-2152.
Crossref
Antonio Palumbo, Patrizia Falco, Antonietta Falcone, Giulia Benevolo, Letizia Canepa, Francesca Gay, Alessandra Larocca, Valeria Magarotto, Alessandro Gozzetti, Annalisa Luraschi, Fortunato Morabito, Andrea Nozza, Robert D. Knight, Jerome B. Zeldis, Mario Boccadoro & Maria Teresa Petrucci. (2009) Melphalan, Prednisone, and Lenalidomide for Newly Diagnosed Myeloma: Kinetics of Neutropenia and Thrombocytopenia and Time-to-Event Results. Clinical Lymphoma and Myeloma 9:2, pages 145-150.
Crossref
Jonathan Kaufman, Charise Gleason & Sagar Lonial. (2009) Treatment of relapsed and refractory myeloma. Current Hematologic Malignancy Reports 4:2, pages 99-107.
Crossref
Khaled M. Musallam, Fadi S. Dahdaleh, Ali I. Shamseddine & Ali T. Taher. (2009) Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy. Thrombosis Research 123:5, pages 679-686.
Crossref
Antonio Palumbo, Meletios Dimopoulos, Jesus San Miguel, Jean-Luc Harousseau, Michel Attal, Mohamad Hussein, Stefan Knop, Heinz Ludwig, Marie von Lilienfeld-Toal & Pieter Sonneveld. (2009) Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma. Blood Reviews 23:2, pages 87-93.
Crossref
K Podar, D Chauhan & K C Anderson. (2008) Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia 23:1, pages 10-24.
Crossref
Iyad N Daher & Edward TH Yeh. (2008) Vascular complications of selected cancer therapies. Nature Clinical Practice Cardiovascular Medicine 5:12, pages 797-805.
Crossref
Oihana Murillo, Ainhoa Arina, Sandra Hervas-Stubbs, Anjana Gupta, Brandon McCluskey, Juan Dubrot, Asís Palazón, Arantza Azpilikueta, Maria C. Ochoa, Carlos Alfaro, Sarai Solano, José L. Pérez-Gracia, Babatunde O. Oyajobi & Ignacio Melero. (2008) Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma. Clinical Cancer Research 14:21, pages 6895-6906.
Crossref
Antonio Palumbo, Jesús San Miguel, Pieter Sonneveld, Philippe Moreau, Johannes Drach, Gareth Morgan & Hermann Einsele. (2008) Lenalidomide: A new therapy for multiple myeloma. Cancer Treatment Reviews 34:3, pages 283-291.
Crossref
Smitha Patiyil Menon, S. Vincent Rajkumar, Martha Lacy, Patrizia Falco & Antonio Palumbo. (2008) Thromboembolic events with lenalidomide‐based therapy for multiple myeloma. Cancer 112:7, pages 1522-1528.
Crossref
ADRIAN L HARRIS & DANIELE G. GENERALI. 2008. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery 351 381 .
Patrick J. Hayden, Constantine S. Mitsiades, Kenneth C. Anderson & Paul G. Richardson. (2007) From the bench to the bedside: emerging new treatments in multiple myeloma. Targeted Oncology 3:1, pages 19-29.
Crossref
Cindy H. Chau & William D. Figg. 2008. Angiogenesis. Angiogenesis 421 430 .
Cindy H. Chau, William Dahut & William D. Figg. 2008. Angiogenesis. Angiogenesis 387 394 .
Patrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson & Paul G Richardson. (2007) Novel therapies in myeloma. Current Opinion in Hematology 14:6, pages 609-615.
Crossref
Lodovico Balducci. (2007) Molecular insight in cancer treatment and prevention. The International Journal of Biochemistry & Cell Biology 39:7-8, pages 1329-1336.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Hang Quach, H Miles Prince & Linda Mileshkin. (2007) Treatment Strategies in Elderly Patients with Multiple Myeloma. Drugs & Aging 24:10, pages 829-850.
Crossref
Shridhar Hegde & Michelle Schmidt. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42 505 554 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.